XML 79 R63.htm IDEA: XBRL DOCUMENT v3.25.1
Shareholders’ Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Oct. 02, 2023
Nov. 09, 2021
Feb. 18, 2021
Feb. 11, 2021
Feb. 09, 2021
Jan. 15, 2021
Jan. 07, 2021
Dec. 22, 2020
Mar. 29, 2021
Feb. 24, 2021
Dec. 31, 2024
Mar. 15, 2024
Dec. 31, 2023
Shareholders’ Equity [Line Items]                          
Ordinary shares authorized                     6,000,000,000   6,000,000,000
Ordinary shares, par value (in Dollars per share)                     $ 0.001   $ 0.001
Sale of stock number of shares 39,171,620                        
Exercise price (in Dollars per share)             $ 5.55         $ 1.5  
Warrant description                     The February Inducement Warrants have substantially the same terms as the January Inducement Warrants, except for having (i) registration rights whereby the Company agreed to register the ADSs underlying the February Inducement Warrants within twenty-one (21) days of closing, and (ii) an exercise price of $4.05 per ADS.    
Purchase of warrants                       10,466,664  
Share of the Company, par value (in Dollars per share) $ 4.57                        
Price per unit (in Dollars per share) $ 0.45655                        
Sale of Stock, Consideration Received Per Transaction (in Dollars) $ 17,880                        
Registered Direct Offering in December 2020 [Member]                          
Shareholders’ Equity [Line Items]                          
Exercise price (in Dollars per share)               $ 4.65          
January 2021 Warrant Solicitation [Member]                          
Shareholders’ Equity [Line Items]                          
Warrant description                     The January Inducement Warrants have substantially the same terms as the Existing Warrants, except for having (i) provisions customary for an unregistered warrant, including a restrictive legend, (ii) registration rights whereby the Company agreed to register the ADSs underlying the January Inducement Warrants within fifteen (15) days of closing, (iii) being exercisable immediately upon issuance, (iv) having a term of five (5) years from the date of issuance, and (v) having an exercise price of $2.00 per ADS.    
February 2021 Warrant Solicitations [Member]                          
Shareholders’ Equity [Line Items]                          
Warrant description                     The Second February Inducement Warrants have substantially the same terms as the February Inducement Warrants, except for having (i) registration rights whereby the Company agrees to register the ADSs underlying the Second February Inducement Warrants within eight (8) days of closing, and (ii) an exercise price $7.00 per ADS.    
Registered Direct Offerings in February 2021 [Member]                          
Shareholders’ Equity [Line Items]                          
Purchase of warrant                 25,000,000        
Exercise price (in Dollars per share)     $ 30 $ 15                  
Ordinary shares [Member]                          
Shareholders’ Equity [Line Items]                          
Ordinary shares authorized                         6,000,000,000
ADS [Member]                          
Shareholders’ Equity [Line Items]                          
Exercise price (in Dollars per share) $ 0.57069                        
Share of the Company, par value (in Dollars per share) 0.005                        
Price per unit (in Dollars per share) $ 5.71                        
November Spa [Member]                          
Shareholders’ Equity [Line Items]                          
Sale of stock number of shares   51,500,000                      
Gross proceeds (in Dollars)   $ 90,100                      
Securities Purchase Agreement [Member] | Warrant [Member]                          
Shareholders’ Equity [Line Items]                          
Purchase of warrants                 25,000,000        
Securities Purchase Agreement [Member] | Registered Direct Offering in December 2020 [Member]                          
Shareholders’ Equity [Line Items]                          
Sale of stock number of shares               2,600,000          
Purchase of warrant               2,600,000          
Gross proceeds from warrants (in Dollars)               $ 4,000          
Issuance for period term               5 years          
Exercise price (in Dollars per share)               $ 1.55          
Purchase per share price (in Dollars per share)               $ 1.55          
Securities Purchase Agreement [Member] | Registered Direct Offering in January 2021 [Member]                          
Shareholders’ Equity [Line Items]                          
Sale of stock number of shares             13,525,000            
Purchase of warrant             13,525,000            
Gross proceeds from warrants (in Dollars)             $ 25,000            
Issuance for period term             5 years            
Exercise price (in Dollars per share)             $ 1.85            
Purchase per share price (in Dollars per share)             $ 1.85            
Securities Purchase Agreement [Member] | January 2021 Warrant Solicitation [Member]                          
Shareholders’ Equity [Line Items]                          
Purchase of warrant           14,925,000              
Unexercised existing warrants (in Dollars)           $ 27,100              
Securities Purchase Agreement [Member] | January Inducement Warrants [Member]                          
Shareholders’ Equity [Line Items]                          
Purchase of warrant           23,880,000              
Securities Purchase Agreement [Member] | February 2021 Warrant Solicitations [Member]                          
Shareholders’ Equity [Line Items]                          
Purchase of warrant         23,880,000         23,880,000      
Gross proceeds from warrants (in Dollars)         $ 48,000         $ 96,700      
Exchange for exercise warrant         23,880,000                
Securities Purchase Agreement [Member] | Second February Inducement Warrants [Member]                          
Shareholders’ Equity [Line Items]                          
Purchase of warrant                   23,880,000      
Securities Purchase Agreement [Member] | Registered Direct Offerings in February 2021 [Member]                          
Shareholders’ Equity [Line Items]                          
Sale of stock number of shares     8,600,000 22,000,000                  
Purchase of warrant     4,300,000 16,500,000                  
Gross proceeds from warrants (in Dollars)     $ 86,000 $ 110,000                  
Issuance for period term     5 years 5 years                  
Exercise price (in Dollars per share)     $ 10 $ 5                  
Purchase per share price (in Dollars per share)     $ 10 $ 5                  
Class A [Member]                          
Shareholders’ Equity [Line Items]                          
Shares issued                     444,677,724   6,099,608,450
Class A [Member] | Registered Direct Offerings in February 2021 [Member]                          
Shareholders’ Equity [Line Items]                          
Warrants to purchase ordinary shares                 250,000,000        
Class A [Member] | Ordinary shares [Member]                          
Shareholders’ Equity [Line Items]                          
Ordinary shares, par value (in Dollars per share)                         $ 0.0001
Class A [Member] | Securities Purchase Agreement [Member]                          
Shareholders’ Equity [Line Items]                          
Ordinary shares                 250,000,000        
Class B [Member]                          
Shareholders’ Equity [Line Items]                          
Shares issued                     24,481,451   698,562,525
Class B [Member] | Ordinary shares [Member]                          
Shareholders’ Equity [Line Items]                          
Ordinary shares, par value (in Dollars per share)                         $ 0.0001